Targeting KCNT1: Rapid Seizure Suppression and Unexpected Risks Found in an N-of-1 ASO Trial
Their names are confidential, but their story and contribution to the field of rare disease are not. Patient one was born as an apparently healthy baby girl and discharged quickly after birth. However, on her fourth day of life, the seizures — unrelenting at ...
CRISPR Therapy Reduces HAE Attacks After a Single Infusion in Phase 3
Hereditary angioedema (HAE) is a rare genetic disease that causes severe and unpredictable swelling attacks due to an overproduction of bradykinin. These attacks often affect the face, airways, abdomen, and extremities and can be life-threatening. Normally, bradykinin is produced through a process called the ...



